Free Trial

BioLargo Q2 2023 Earnings Report

BioLargo logo
$0.28 +0.00 (+0.36%)
As of 03/28/2025 03:57 PM Eastern

BioLargo EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BioLargo Revenue Results

Actual Revenue
$1.45 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BioLargo Announcement Details

Quarter
Q2 2023
Time
N/A
Remove Ads

BioLargo Earnings Headlines

Trump’s Great Society
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
BioLargo (OTC: BLGO)
BioLargo provides 2025 corporate outlook
See More BioLargo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioLargo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioLargo and other key companies, straight to your email.

About BioLargo

BioLargo (NASDAQ:BLGO) invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.

View BioLargo Profile

More Earnings Resources from MarketBeat